Latest Breaking News On - Brett whelan - Page 1 : comparemela.com

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - X4 Pharmaceuticals (NASDAQ:XFOR)

BOSTON, Dec. 04, 2023 (GLOBE NEWSWIRE) X4 Pharmaceuticals (NASDAQ:XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on November 30, 2023,

United statesBrett whelanPharmaceuticals incLifesci communicationsCompensation committee of the board directorsEquity incentive planNasdaq listing rule

X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates

X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoChristophe arbet engelsPaula raganBrett whelanManagement teamCompany board of directorsLifesci communicationsExchange commissionDevelopment rd expensesPharmaceuticals nasdaqMeeting of the american society hematologyDrug administrationDrug applicationPriority reviewPriority review voucher

X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates

X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesSan diegoPaula raganBrett whelanChristophe arbet engelsCompany board of directorsLifesci communicationsMeeting of the american society hematologyExchange commissionPharmaceuticals nasdaqManagement teamDevelopment rd expensesDrug administrationDrug applicationPriority reviewPriority review voucher

X4 Pharmaceuticals to Report Third-Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 9, 2023

X4 Pharmaceuticals to Report Third-Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 9, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesBrett whelanPharmaceuticals incLifesci communicationsPharmaceuticals to report thirdReport third quarterConference call

X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U S NDA for Mavorixafor in WHIM Syndrome

X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U S NDA for Mavorixafor in WHIM Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPaula raganBrett whelanPharmaceuticals nasdaqEuropean unionEuropean hematology associationLifesci communicationsExchange commissionDrug administrationClinical immunology societyPrescription drug user fee actPriority review voucherUnited states foodNew drug applicationPriority reviewChief executive officer